1. 462PDPostoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial. (23rd October 2018) Authors: Auclin, E; Andre, T; Taieb, J; Banzi, M; van Laethem, J-L; Tabernero, J; Hickish, T; de Gramont, A; Vernerey, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 470PSafety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC). (23rd October 2018) Authors: Calvo Ferrandiz, A; Dahan, L; Hollebecque, A; Prager, G; Andre, T; Argiles Martinez, G; Bordonaro, R; Stein, A; Tortora, G; Leger, C; Amellal, N; Tabernero, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗